Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
54.19
0.05 (0.09%)
At close: Aug 15, 2025, 3:59 PM
54.49
0.56%
After-hours: Aug 15, 2025, 06:30 PM EDT
Tarsus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 295.52M | 233.67M | 182.95M | 129.62M | 83.37M | 42.56M | 17.45M | 14.37M | 12.5M | 27.78M | 25.82M | 16.15M | 17.39M | 24.13M | 57.03M | 56.69M | 55.45M | 33.43M |
Cost of Revenue | 19.62M | 16.38M | 12.83M | 9.12M | 6.25M | 3.25M | 1.85M | 1.03M | 11.57M | 12.09M | 11.87M | 19.48M | 8.63M | 8.85M | 10.11M | 2.1M | 2.03M | 1.3M |
Gross Profit | 275.9M | 217.29M | 170.13M | 120.5M | 77.12M | 39.31M | 15.6M | 13.34M | 933K | 15.69M | 13.95M | -3.33M | 8.76M | 15.29M | 46.91M | 54.59M | 53.41M | 32.13M |
Operating Income | -98.05M | -109.17M | -120.57M | -140.6M | -156.37M | -155.89M | -143.16M | -113.77M | -95.74M | -68.14M | -62.71M | -62.1M | -54.9M | -42.39M | -12.16M | -9.19M | -3.62M | -14.17M |
Interest Income | 15.45M | 15.35M | 15.01M | 14.35M | 13.06M | 11.16M | 10.34M | 9.49M | 7.71M | 5.78M | 3.48M | 1.36M | 305.04K | 8.04K | 8.04K | 8K | n/a | n/a |
Pretax Income | -91.99M | -104.94M | -115.55M | -134.34M | -151.86M | -149.99M | -137.68M | -109.38M | -90.96M | -65.28M | -62.09M | -63.29M | -56.81M | -44.7M | -13.77M | -10.44M | -4.54M | -14.16M |
Net Income | -91.99M | -104.94M | -115.55M | -134.34M | -150.07M | -148.21M | -134.36M | -105.54M | -88.9M | -63.22M | -61.57M | -63.34M | -56.53M | -44.44M | -13.83M | -10.44M | -4.88M | -14.48M |
Selling & General & Admin | 314.95M | 270.73M | 237.31M | 211.28M | 183.7M | 145.18M | 108.7M | 80.33M | 62M | 52.1M | 44.95M | 37.09M | 31.77M | 28.18M | 25.4M | 22.52M | 17.99M | 12.73M |
Research & Development | 59M | 55.73M | 53.39M | 49.82M | 49.8M | 50.02M | 50.31M | 47.03M | 45.84M | 42.9M | 42.62M | 40.63M | 39.93M | 37.53M | 41.71M | 41.26M | 39.04M | 33.58M |
Other Expenses | n/a | n/a | 605K | 592K | 544K | 544K | -55K | -92K | -51K | -51K | -20K | 25K | 37K | -2K | -73K | -68K | -73K | -34K |
Operating Expenses | 373.95M | 326.46M | 290.7M | 261.1M | 233.49M | 195.2M | 159.01M | 127.36M | 107.84M | 95M | 87.57M | 77.72M | 71.7M | 65.72M | 67.11M | 63.78M | 57.04M | 46.3M |
Interest Expense | 9.21M | 9.08M | 7.85M | 6.53M | 4.94M | 3.65M | 3.35M | 3.05M | 2.82M | 2.55M | 2.19M | 1.49M | 860K | 323K | 16K | 204K | 208K | 201K |
Selling & Marketing Expenses | n/a | n/a | n/a | -22.69M | -22.69M | -22.69M | -22.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 393.57M | 342.84M | 303.52M | 270.22M | 239.75M | 198.45M | 160.6M | 128.14M | 108.24M | 95.92M | 88.53M | 78.25M | 72.29M | 66.53M | 69.18M | 65.88M | 59.07M | 47.6M |
Income Tax Expense | n/a | n/a | -270K | -270K | -2.06M | -2.06M | -3.32M | -3.84M | -2.06M | -2.06M | -525K | 50K | -286K | -257K | 55K | n/a | 342K | 313K |
Shares Outstanding (Basic) | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 26.73M | 26.66M | 24.33M | 20.65M | 20.56M | 20.64M | 20.56M | 20.34M |
Shares Outstanding (Diluted) | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 26.73M | 26.66M | 24.33M | 20.71M | 20.64M | 20.64M | 21.97M | 21.82M |
EPS (Basic) | -2.34 | -2.74 | -3.11 | -3.81 | -4.48 | -4.77 | -4.58 | -3.76 | -3.32 | -2.39 | -2.55 | -2.78 | -2.7 | -2.15 | -0.66 | -0.5 | -0.28 | -0.89 |
EPS (Diluted) | -2.34 | -2.74 | -3.11 | -3.81 | -4.48 | -4.77 | -4.58 | -3.76 | -3.32 | -2.39 | -2.55 | -2.78 | -2.7 | -2.17 | -0.72 | -0.53 | -0.31 | -0.9 |
EBITDA | -84.97M | -98.27M | -106.46M | -126.66M | -143.91M | -143.39M | -131.39M | -103.52M | -87.27M | -61.95M | -59.23M | -60.95M | -55.15M | -42.63M | -12.09M | -9.12M | -3.37M | -14.02M |
EBIT | -87.34M | -100.42M | -107.87M | -128.01M | -145.23M | -144.66M | -132.61M | -104.57M | -88.18M | -62.77M | -59.96M | -61.5M | -55.61M | -44.03M | -13.42M | -10.45M | -4.55M | -14.19M |
Depreciation & Amortization | 2.22M | 2.01M | 1.23M | 1.14M | 1.23M | 1.17M | 1.15M | 1.02M | 750K | 660K | 883K | 704K | 693K | 726K | 312K | 312K | 253K | 145K |